Biological & Fonctional Signatures for Muscle Failures, Aged People & Personalized Physical Activity

NCT ID: NCT05343286

Last Updated: 2025-12-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

900 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-29

Study Completion Date

2028-04-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Physical activity is one of the most effective therapeutic interventions for frailty, sarcopenia or dynapenia. The benefits of physical activity processes are already widely documented. Typically, researchers want to understand the average response to an intervention to determine its overall effectiveness. However, sports trainers have understood it for a long time, the response of an athlete or a patient to training is very variable and the standard deviations present in all the scientific studies on the subject confirm it. There is therefore inter-individual variation in the response to exercise, with some subjects showing much greater improvements than others. Thus, one can wonder if this "non-response" following training is specific to the training modality. The effects of physical exercise on the body depend mainly on its type, intensity and duration. Thus, from a practical point of view, the most important perspective is the prediction and, ultimately, the individual optimization of management through physical activity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Main objective: To determine the effects of personalized physical activity management on the biological signatures of muscle failure.

Secondary objectives:

* Propose a support system through adapted and individualized physical activity, based on physical, biological and psycho-social indicators
* Identify the biological signatures (metabolomics, epigenetic) of muscle failure in the elderly.

Phenotype responders and non-responders in training

900 seniors (300 per group) APAP group: adapted and personalized physical activity APA group: adapted physical activity Control group: no physical activity

Total duration of the study 5 years, duration of participation for a patient 3 months; inclusion period: 57 months

Improvement of muscle failure in its broad definition (Strength, power, speed and lean mass)

) General data: description of characteristics with frequencies and percentage for categorical variables and with mean and standard deviation for quantitative variables.

ii) Analysis of the primary endpoint: Machine Learning (or supervised classification) and signaling pathway prediction approaches for statistical analysis and data interpretation.

iii) Analysis of secondary judgment criteria: approaches in Machine Learning (or supervised classification) and signaling pathway prediction for statistical analysis and interpretation of data with comparison of quantitative variables by Pearson correlation and categorical variables by t or chi 2 test depending on the case.

Adapt and individualize physical activity support for healthy or frail elderly people

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Elderly

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

APAP group: adapted and personalized physical activity

12 weeks of adapted and personalized physical activity

Group Type EXPERIMENTAL

blood sample

Intervention Type PROCEDURE

blood sample before and after 12 weeks of physical activity

physical assessement

Intervention Type OTHER

physical assessement before and after 12 weeks of physical activity

* Standardized geriatric assessment (physician visit)
* ICOPE Monitor Assessment
* Sit-to-stand Test
* Quantified Gait Analysis (QAM)
* Bone densitometer measurement of body composition

psychometric assessment

Intervention Type BEHAVIORAL

Psychometric questionnaires

* Cognitive tests (MMSE)
* The long questionnaire of personality traits: Big Five Inventory
* Perceived health and subjective age
* Age group identification
* Attitudes towards aging: French version of the Attitudes Toward Own Aging scale
* Physical self-perception: French version of the Physical Self-Perception Profile
* MOTIVATION SCALE FOR PA FOR HEALTH PURPOSES: Motivation Scale for Physical Activity in a Health Context
* Aging Stereotypes and Exercise Scale

APA group: adapted physical activity

12 weeks of generic physical activity

Group Type ACTIVE_COMPARATOR

blood sample

Intervention Type PROCEDURE

blood sample before and after 12 weeks of physical activity

physical assessement

Intervention Type OTHER

physical assessement before and after 12 weeks of physical activity

* Standardized geriatric assessment (physician visit)
* ICOPE Monitor Assessment
* Sit-to-stand Test
* Quantified Gait Analysis (QAM)
* Bone densitometer measurement of body composition

psychometric assessment

Intervention Type BEHAVIORAL

Psychometric questionnaires

* Cognitive tests (MMSE)
* The long questionnaire of personality traits: Big Five Inventory
* Perceived health and subjective age
* Age group identification
* Attitudes towards aging: French version of the Attitudes Toward Own Aging scale
* Physical self-perception: French version of the Physical Self-Perception Profile
* MOTIVATION SCALE FOR PA FOR HEALTH PURPOSES: Motivation Scale for Physical Activity in a Health Context
* Aging Stereotypes and Exercise Scale

Control group: no physical activity

no physical activity

Group Type SHAM_COMPARATOR

blood sample

Intervention Type PROCEDURE

blood sample before and after 12 weeks of physical activity

physical assessement

Intervention Type OTHER

physical assessement before and after 12 weeks of physical activity

* Standardized geriatric assessment (physician visit)
* ICOPE Monitor Assessment
* Sit-to-stand Test
* Quantified Gait Analysis (QAM)
* Bone densitometer measurement of body composition

psychometric assessment

Intervention Type BEHAVIORAL

Psychometric questionnaires

* Cognitive tests (MMSE)
* The long questionnaire of personality traits: Big Five Inventory
* Perceived health and subjective age
* Age group identification
* Attitudes towards aging: French version of the Attitudes Toward Own Aging scale
* Physical self-perception: French version of the Physical Self-Perception Profile
* MOTIVATION SCALE FOR PA FOR HEALTH PURPOSES: Motivation Scale for Physical Activity in a Health Context
* Aging Stereotypes and Exercise Scale

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

blood sample

blood sample before and after 12 weeks of physical activity

Intervention Type PROCEDURE

physical assessement

physical assessement before and after 12 weeks of physical activity

* Standardized geriatric assessment (physician visit)
* ICOPE Monitor Assessment
* Sit-to-stand Test
* Quantified Gait Analysis (QAM)
* Bone densitometer measurement of body composition

Intervention Type OTHER

psychometric assessment

Psychometric questionnaires

* Cognitive tests (MMSE)
* The long questionnaire of personality traits: Big Five Inventory
* Perceived health and subjective age
* Age group identification
* Attitudes towards aging: French version of the Attitudes Toward Own Aging scale
* Physical self-perception: French version of the Physical Self-Perception Profile
* MOTIVATION SCALE FOR PA FOR HEALTH PURPOSES: Motivation Scale for Physical Activity in a Health Context
* Aging Stereotypes and Exercise Scale

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age greater than or equal to 60 years
* Affiliated patient or beneficiary of a social security scheme
* Patient having signed a prior informed consent.

Exclusion Criteria

* Neurocognitive disorder preventing the expression of informed consent
* Patients protected by law under guardianship or curatorship, or who cannot participate in a clinical study under Article L. 1121-16 of the French Public Health Code
* Presence of a physical or cognitive pathology preventing the performance of the adapted physical activity protocol over 3 months.
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Nice

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Olivier GUERIN, PU-PH

Role: PRINCIPAL_INVESTIGATOR

geriatric Department

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Nice

Nice, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Olivier GUERIN, PU-PH

Role: CONTACT

0492034194

Fréderic CHORIN, PhD

Role: CONTACT

0492034924

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Olivier Guérin, PU-PH

Role: primary

+33 (0)4 92 03 41 94

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

21-PP-24

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.